Oat beta-glucan is expected to account for 45.0% of the product category in 2026, supported by its recognized role in soluble fiber enrichment and formulation versatility across functional food applications. Metabolic health applications are projected to represent 38.0% share, driven by growing interest in ingredients associated with glucose management and broader wellness-focused product development.